2025-09-06 - Analysis Report
Okay, here's the analysis of Albemarle Corp (ALB), incorporating the provided data and focusing on key observations and potential investment implications.

## Albemarle Corp (ALB) Analysis

Albemarle Corp. is a specialty chemicals company with leadership positions in lithium, bromine, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return Difference:** ALB's cumulative return is significantly lagging behind the S&P 500 (VOO).
    *   ALB: 24.18%
    *   VOO: 101.31%
    *   Difference: -75.0
*   **Disparity Range:** The disparity between ALB and VOO has fluctuated considerably (Min: -90.2, Max: 312.9).
*   **Relative Disparity:** The current relative disparity is 3.8, indicating ALB is near the lower end of its historical performance relative to the S&P 500.

**Analysis:** ALB has significantly underperformed the S&P 500, and this underperformance is near its historical worst.

| Year       | CAGR   | MDD    | Alpha   | Beta  | Cap(B) |
|------------|--------|--------|---------|-------|--------|
| 2015-2017  | 99.0%  | 8.1%   | 70.0%   | 0.0   | 15.1   |
| 2016-2018  | 13.0%  | 58.0%  | -5.0%   | 0.0   | 9.1    |
| 2017-2019  | -44.0% | 58.0%  | -74.0%  | -0.0  | 8.6    |
| 2018-2020  | 101.0% | 62.9%  | 81.0%   | 0.6   | 17.4   |
| 2019-2021  | 268.0% | 62.9%  | 220.0%  | 0.6   | 27.5   |
| 2020-2022  | 239.0% | 75.6%  | 237.0%  | 0.8   | 25.5   |
| 2021-2023  | -53.0% | 77.5%  | -71.0%  | 0.6   | 17.0   |
| 2022-2024  | -200.0%| 77.5%  | -225.0% | 0.7   | 10.1   |
| 2023-2025  | -324.0%| 77.5%  | -377.0% | 2.9   | 9.6    |

**Analysis of Table:**

*   **CAGR:** The Compounded Annual Growth Rate shows extreme volatility, ranging from significant gains (e.g., 268% in 2019-2021) to substantial losses (e.g., -324% in 2023-2025). This highlights the stock's sensitivity to market conditions and industry-specific factors.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant risk exposure. Values around 60-77% indicate that investors may experience substantial losses during downturns.
*   **Alpha:** Alpha values are also highly volatile. Positive alpha indicates outperformance relative to the market, while negative alpha signifies underperformance. The trend shows negative alpha in recent periods, suggesting the stock has not performed well compared to its benchmark.
*   **Beta:** Beta values vary, but some periods have high beta values (e.g. 2.9 in 2023-2025), which suggests the stock's volatility is more pronounced compared to the broader market.
*   **Cap(B):** Market capitalization fluctuates, indicating changes in investor sentiment and overall market conditions.

### 2. Recent Price Action

*   **Current Price:** $81.54
*   **Previous Close:** $79.27
*   **Change:** $2.86 (Positive change)
*   **Moving Averages:**
    *   5-day MA: 81.214
    *   20-day MA: 81.152
    *   60-day MA: 72.7505

**Analysis:** The stock is trading above its 5-day, 20-day, and 60-day moving averages, suggesting a short-term bullish trend. The recent price increase ($2.86) confirms this upward momentum.  The fact that price is way above 60-day MA shows strong recent recovery.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3322 (Low Risk)
*   **RSI:** 48.76 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.698 (Negative - indicates a potential downtrend)
*   **Hybrid Signal:** cash_69%_Sell 0.8% of holdings (5 shares - Caution - MRI:0.33) (Cash Ratio: 69% on 2025-09-05)
*   **Recent (20-day) Relative Disparity Change:** 0.0 (Short-term decline)
*   **Expected Return (%):** 2697.7 (Long-term, relative to S&P 500)

**Analysis:** The MRI suggests low market risk. The RSI is neutral. The PPO indicates a possible downtrend. The "Hybrid Signal" advises caution and suggests a partial sell-off to increase cash holdings. A high expected return over the long term is projected, but this should be viewed cautiously given the stock's volatility. The recent price jump should be viewed in context with cautionary MRI signals.

### 4. Recent News & Significant Events

*   **Positive News:**
    *   China's lithium strategy boosting ALB.
    *   ALB was a top performer in the S&P 500 in August.
    *   Stock is up significantly since the last earnings report.
*   **Negative/Cautionary News:**
    *   Wall Street doubts the sustainability of the recent rally.
    *   Baird adjusted the price target *down* and maintains an "Underperform" rating.

**Analysis:** Recent news presents a mixed picture. While some factors have boosted the stock, analysts are wary about the rally's longevity. The Baird downgrade is a negative signal.

### 4-2. Analyst Opinions

*   **Consensus:** Hold
*   **Mean Rating:** 2.64 (~Hold)
*   **Target Price:** $85.47 (Average), $200 (High), $58 (Low)

**Analysis:** The consensus rating is "Hold," indicating analysts are generally neutral. The wide range in target prices ($58 to $200) reflects significant uncertainty about the stock's future.

### 5. Recent Earnings Analysis

| 날짜       | EPS    | 매출       |
|------------|--------|------------|
| 2025-08-04 | -0.16  | 1.33 B$    |
| 2025-04-30 | 0      | 1.08 B$    |
| 2024-11-06 | -9.45  | 1.35 B$    |
| 2024-07-31 | -1.96  | 1.43 B$    |
| 2025-08-04 | -1.96  | 1.43 B$    |

**Analysis:** Recent EPS figures are negative or near zero, indicating profitability issues. Revenue has fluctuated, with a recent decline.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $1.33B  | 14.80%       |
| 2025-03-31 | $1.08B  | 14.51%       |
| 2024-12-31 | $1.23B  | 11.22%       |
| 2024-09-30 | $1.35B  | -7.68%        |
| 2024-06-30 | $1.43B  | -0.74%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
|------------|-----------|----------|
| 2025-06-30 | $10.24B   | 0.22%    |
| 2025-03-31 | $10.03B   | 0.41%    |
| 2024-12-31 | $9.96B    | 0.76%    |
| 2024-09-30 | $10.24B   | -10.44%   |
| 2024-06-30 | $11.22B   | -1.68%    |

**Analysis:**

*   **Revenue:** Revenue has fluctuated over the past five quarters, indicating variability in sales performance.
*   **Profit Margin:** The profit margin shows significant swings, with negative values in some quarters. This suggests challenges in maintaining profitability, possibly due to cost fluctuations or pricing pressures.
*   **Equity:** Equity has remained relatively stable, but has seen a decline over the period.
*   **ROE:** Return on Equity has been volatile, with negative values indicating poor returns on shareholder equity in some quarters.

### 7. Overall Summary

Albemarle (ALB) presents a mixed investment picture:

*   **Negative:**
    *   Significant underperformance relative to the S&P 500.
    *   Recent negative EPS and fluctuating revenue.
    *   Analyst concerns about the sustainability of the recent rally.
    *   High historical volatility (MDD).
*   **Positive:**
    *   Recent positive price momentum.
    *   Potential long-term upside (high expected return), though this should be viewed cautiously.
    *   China's lithium strategy could be a tailwind.
    *   Low market risk indicator (MRI).

**Investment Recommendation:** Given the high volatility, underperformance, and mixed analyst opinions, a cautious approach is warranted. The "Hold" consensus seems appropriate.  While there may be long-term potential related to lithium demand, the current financial performance and market sentiment suggest that ALB carries significant risk.
